Barclays raised the firm’s price target on Bath & Body Works to $35 from $31 and keeps an Equal Weight rating on the shares. The CEO change is focused on profitable growth and Bath & Body also announced a positive Q1 preannouncement, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works: Strong Earnings and Strategic Leadership Drive Buy Rating
- Bath & Body Works: Strategic Leadership and Strong Fundamentals Drive Buy Rating
- BofA remains bullish on Bath & Body Works following CEO appointment
- Moody’s cuts U.S. rating, Trump urges Walmart to ‘eat’ tariffs: Morning Buzz
- Bath & Body Works (BBWI) Names Former Nike Executive as Its New CEO